TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Sever Pharma Solutions AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
54,807
|
46,726
|
43,878 |
Financial expenses |
518
|
391
|
288 |
Earnings before taxes |
1,517
|
2,734
|
2,341 |
EBITDA |
4,013
|
4,773
|
3,695 |
Total assets |
49,151
|
44,559
|
42,826 |
Current assets |
25,091
|
19,277
|
16,836 |
Current liabilities |
17,409
|
9,218
|
7,204 |
Equity capital |
29,713
|
22,256
|
20,509 |
- share capital |
899
|
978
|
996 |
Employees (average) |
312
|
278
|
256 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
60.5%
|
49.9%
|
47.9% |
Turnover per employee |
176
|
168
|
171 |
Profit as a percentage of turnover |
2.8%
|
5.9%
|
5.3% |
Return on assets (ROA) |
4.1%
|
7.0%
|
6.1% |
Current ratio |
144.1%
|
209.1%
|
233.7% |
Return on equity (ROE) |
5.1%
|
12.3%
|
11.4% |
Change turnover |
11,866
|
3,661
|
9,208 |
Change turnover % |
28%
|
9%
|
27% |
Chg. No. of employees |
34
|
22
|
55 |
Chg. No. of employees % |
12%
|
9%
|
27% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.